Литература. 
Последние результаты в медикаментозном лечении доброкачественной гиперплазия предстательной железы

1. Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CM4/2004;] 71:466−72.

2. Ambrose NS, Johnson M, Burdon DW, Keighly MRB. The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile./ Antimicrob Chemother 1985;15:319−26.

3. Aronnson B, Mollby R, Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980;1982.//ґ/ґ* Dis 1985;151:476−81.

4. Phillips KD, Rogers PA. Rapid detection and presumptive identification of Clostridium difficile by p-cresol production on a selective medium./ Clin Pathol 1981;34:642−4.

5. Bender BS, Bennett R, Laughon BE, Greenough WB, Gaydos C, Sears SD, et al. Is Clostridium difficile endemic in chronic-care facilities? Lancet 1986;2:11−3.

6. Brazier JS, Fitzgerald TC, Hosein I, Cefai C, Looker N, Walker M, et al. Screening for carriage and nosocomial acquisition of Clostridium difficile by culture: a study of 284 admissions of elderly patients to six general hospitals in Wales./Hosp Infect 1999;43:317−9.

7. McCoubrey J, Starr JM, Martin H, Poxton IR. Clostridium difficile: a prospective study in a geriatric unit. J Med Microbiol 2003;52:573−8.

8. Von Eichel-Streiber C, Boquet P, Sauerborn M, Thelestam M. Large clostridial cytotoxinsЧa family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol 1996;4:375−82.

9. Geric B, Johnson S, Gerding DN, Grabnar M, Rupnik M. Frequency of binary toxin genes among Clostridium difficile strains that do not produce large Clostridial toxins./ Clin Microbiol 2003;41:5227−32.

10. Bignardi GE. Risk factors for Clostridium difficile infection./ Hosp Infect 1998;40:1−15.

11. Thomas C, Stevenson M, Riley TV. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. / Antimicrob Chemother 2003;51:1339−50.

12. Starr JM, Martin H, McCoubrey J, Gibson G, Poxton IR. Risk factors for Clostridium difficile colonisation and toxin production. Age Ageing 2003;32:657−60.

13. Mulligan ME, Miller SD, McFarland LV, Fung HC, Kwok RY. Elevated levels of serum immunoglobulins in asymptomatic carriers of Clostridium difficile. Clin Infect LHs 1993;16(Suppl 4):S239−44.

14. Kyne L, Warny M, Qamat A, Kelly CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001;357:189−93.

15. Starr JM, Rogers TR, Impallomeni M. Hospital acquired Clostridium difficile diarrhoea and herd immunity. Lancet 1997;349:426−8.

16. Fernandez A, Anand G, Friedenberg F. Factors associated with failure of metronidazole in Clostridium difficile-associated disease./ Clin Gastroen-terol 2004;38:414−8.

17. Zimmerman MJ, Bak A, Sutherland LR. Review article: treatment of Clostridium difficile infection. Aliment Pharmacol Ther 1997;ll:f 003−12.

18. Lewis SJ, Potts LF, Barry RE. The lack of therapeutic effect of Saccharo-myces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients./ Infect 1998;36:171−4.

19. Brazier JS, Duerden BI. Guidelines for optimal surveillance of Clostridium difficile infection in hospitals. Comm Dis Pub Health 1998;1:229−30.

20. Gerding DN, Brazier JS. Optimal methods for identifying Clostridium difficile infections. Clin Infect Dis 1993;16(Suppl 4):S439−42.

21. Stone SP, Berk V, Quick A, Balestrini AA, Kibbler CC. The effect of an enhanced infection-control policy on the incidence of Clostridium difficile infection and methicillin-resistant Staphylococcus aureus colonization in acute elderly medical patients. Age Ageing 1998;27: 561 -8.

22. Zafar AB, Gaydos LA, Furlong WB, Nguyen MH, Mennonna PA. Effectiveness of infection control program in controlling nosocomial Clostridium difficile. Am J Infect Control 1998;26:588−93.

23. King S. Provision of alcohol hand rub at the hospital bedside: a case study./ Hosp Infect 20()4;56(Suppl 2):S1()-12.

24. Wilcox MH, Fawley WN, Wigglesworth N, Parnell P, Verity P, Freeman J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection./Hosp Infect 2003;54:109−14.

25. Berild D, Smaabrekke L, Halvorsen DS, Lelek M, Stahlsberg EM, Ringcrtz SH. Clostridium difficile infections related to antibiotic use and infection control facilities in two university hospitals./ Hosp Infect 2003;54:202−6.

26. Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000;31:1012−7.

27. Hummer S, Weaver MA, Harris JC, Dee P, Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C difficile diarrhoea. Int Microbiol 2004;7:59−62.

28. Berrington A, Borriello SP, Brazier J, Duckworth G, Foster K, Freeman R, et al. National Clostridium difficile Standards Group: report to the Department of Health./ Hosp Infect 2004;56(Suppl l):l-38.

29. Johal SS, Lambert CP, Hammond J, James PD, Borriello SP, Mahida YR. Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea./ Clin Pathol 2004;57:973−9.

30. Wilcox MH. Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea./ Antimicrob Chemother 2004;53:882−4.